J Rubio-Retama1, F Tamimi Mariño, E López-Cabarcos
1Department of Pharmaceutical Chemical-Physics, University Complutense of Madrid, 28040 Madrid, Spain. bjrubio@farm.ucm.es
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers developed poly(epsilon-caprolactone) microparticles for enzymatic therapy, successfully encapsulating Glucose Oxidase. These micro-reactors retain significant enzymatic activity, showing promise for drug immobilization systems.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: